YuLife raises further funding from T. Rowe Price
YuLife has raised further funding from T. Rowe Price which will support the company’s expansion into the US benefits market. YuLife has stated that in July this year it raised $120m Series...
YuLife has raised further funding from T. Rowe Price which will support the company’s expansion into the US benefits market. YuLife has stated that in July this year it raised $120m Series...
SPONSORED CONTENT Arguably the most significant change for the Group Risk industry as a result of the pandemic is the widespread adoption of digital health platforms which has not only transformed how...
SPONSORED CONTENT Wellbeing in the workplace has never been more important. Over the last two years, employers have faced significant challenges in supporting their staff throughout the pandemic, but also implementing best...
SPONSORED CONTENT Why now is a great time to talk about group risk to your clients Group risk has really come into its own over the past few years. Not only supporting...
If Legal & General’s latest Wellbeing at Work Barometer data – hot off the press – is anything to go by, there are some considerable wellbeing gaps where many SMEs (50-249 employees)...
The employee benefits sector has strengthened significantly in the wake of the Covid pandemic. The health and wellbeing of staff has now moved towards the top of many employers’ agenda, with the...
The workplace health and protection sector continued to grow across virtually all product lines, with insurers increasing both the number of employees covered and overall number of employer clients across group life,...
SPONSORED CONTENT Most employers instinctively know that wellbeing matters to people and to business. Quantifying how much it matters is another thing entirely. So, it stands to reason that small to medium...
Legal & General paid out over £335m in group protection claims in 2021 - a 4 per cent increase on the year before. There were increases in both the value of life...
It seems natural to have a sense of foreboding about how the group risk claims story might pan out in the wake of the Covid-19 pandemic. We still have little idea exactly what...